We just received data on a new analyst forecast for $PHR. Keybanc gave a rating of 'Overweight' for $PHR.
$PHR Analyst Ratings
Wall Street analysts have issued reports on $PHR in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 10/08/2025
- Truist Securities issued a "Buy" rating on 09/08/2025
- JMP Securities issued a "Market Outperform" rating on 09/08/2025
- Canaccord Genuity issued a "Buy" rating on 05/29/2025
- DA Davidson issued a "Buy" rating on 04/14/2025
To track analyst ratings and price targets for $PHR, check out Quiver Quantitative's $PHR forecast page.
$PHR Price Targets
Multiple analysts have issued price targets for $PHR recently. We have seen 11 analysts offer price targets for $PHR in the last 6 months, with a median target of $34.0.
Here are some recent targets:
- Scott Schoenhaus from Keybanc set a target price of $32.0 on 10/08/2025
- Jailendra Singh from Truist Securities set a target price of $36.0 on 09/08/2025
- Silvan Tuerkcan from JMP Securities set a target price of $34.0 on 09/08/2025
- Ryan MacDonald from Needham set a target price of $35.0 on 09/05/2025
- Lucky Schreiner from DA Davidson set a target price of $33.0 on 09/05/2025
- Jessica Tassan from Piper Sandler set a target price of $34.0 on 09/05/2025
- Richard Close from Canaccord Genuity set a target price of $38.0 on 09/05/2025
$PHR Insider Trading Activity
$PHR insiders have traded $PHR stock on the open market 54 times in the past 6 months. Of those trades, 0 have been purchases and 54 have been sales.
Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
- CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 5 sales selling 112,583 shares for an estimated $3,511,098.
- EVAN ROBERTS (President, Provider Solutions) has made 0 purchases and 5 sales selling 56,045 shares for an estimated $1,738,336.
- DAVID LINETSKY (President, Network Solutions) has made 0 purchases and 13 sales selling 51,505 shares for an estimated $1,445,764.
- AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 4 sales selling 21,599 shares for an estimated $637,144.
- MICHAEL WEINTRAUB has made 0 purchases and 3 sales selling 20,000 shares for an estimated $576,011.
- BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 4 sales selling 15,516 shares for an estimated $429,339.
- ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 5 sales selling 12,346 shares for an estimated $292,775.
- YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 12 sales selling 9,770 shares for an estimated $240,254.
- MARK DOUGLAS SMITH sold 7,000 shares for an estimated $203,000
- LISA EGBUONU-DAVIS has made 0 purchases and 2 sales selling 3,267 shares for an estimated $90,383.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PHR Hedge Fund Activity
We have seen 123 institutional investors add shares of $PHR stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BROWN ADVISORY INC removed 1,287,525 shares (-34.1%) from their portfolio in Q2 2025, for an estimated $36,642,961
- LOOMIS SAYLES & CO L P added 1,200,340 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,161,676
- FMR LLC removed 860,515 shares (-15.0%) from their portfolio in Q2 2025, for an estimated $24,490,256
- NUVEEN, LLC added 748,735 shares (+134.7%) to their portfolio in Q2 2025, for an estimated $21,308,998
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 570,173 shares (-21.6%) from their portfolio in Q2 2025, for an estimated $16,227,123
- CAPITAL INTERNATIONAL INVESTORS added 391,611 shares (+14.3%) to their portfolio in Q2 2025, for an estimated $11,145,249
- CAMBIAR INVESTORS LLC added 375,065 shares (+inf%) to their portfolio in Q2 2025, for an estimated $10,674,349
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
